Literature DB >> 8664509

Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?

A C Farney1, A J Matas, H J Noreen, N Reinsmoen, M Segall, W J Schmidt, K Gillingham, J S Najarian, D E Sutherland.   

Abstract

UNLABELLED: We analyzed 420 kidney retransplants at the University of Minnesota, 87 of which did and 333 which did not share HLA mismatches with the previous transplant. There was no difference in outcome. We conclude that exceptions to routine HLA matching policies do not have to be made for kidney retransplants.
OBJECTIVE: To determine if the kidney graft functional survival rate for retransplants is influenced by presence of HLA mismatches in common with the previous (failed) transplant. SUMMARY BACKGROUND DATA: Kidney retransplants have a lower function rate than primary grafts. An anamnestic response to HLA antigens shared with the previous donor could be one factor responsible, but reports in the literature are conflicting.
METHODS: Of 420 kidney retransplants with HLA information done at the University of Minnesota, 87 shared > or = 1 HLA antigens specifically mismatched with the previous donor (63 cadaver and 24 living donor retransplants), while 333 did not (247 cadaver, 86 living donor). Patient and graft survival rates were calculated by life-table analysis for recipients with vs. without repeat mismatches, with the significance of differences determined by the Lee-Desu statistic.
RESULTS: Patient and kidney graft retransplant survival rate curves were not significantly different (p > or = 0.41) for those exposed or not exposed to the same HLA mismatches as before. At 2 years, 70% vs. 61%, respectively, of cadaver grafts and 71% vs. 78%, respectively, of living donor grafts were functioning.
CONCLUSIONS: The probability of a successful outcome with a kidney retransplant is no different for patients who do than for those who do not receive an organ sharing HLA mismatches with the previous donor. Exceptions to routine HLA matching policies do not need to be made for kidney retransplants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8664509

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

1.  Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation.

Authors:  Kathryn J Tinckam; Caren Rose; Sundaram Hariharan; John Gill
Journal:  J Am Soc Nephrol       Date:  2016-02-17       Impact factor: 10.121

Review 2.  Donor specific antibodies after transplantation.

Authors:  Jeffrey L Platt; Marilia Cascalho
Journal:  Pediatr Transplant       Date:  2011-03-29

Review 3.  Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen.

Authors:  Michelle J Hickey; Nicole M Valenzuela; Elaine F Reed
Journal:  Front Immunol       Date:  2016-02-04       Impact factor: 7.561

Review 4.  Strategies to Overcome HLA Sensitization and Improve Access to Retransplantation after Kidney Graft Loss.

Authors:  Rita Leal; Clara Pardinhas; António Martinho; Helena Oliveira Sá; Arnaldo Figueiredo; Rui Alves
Journal:  J Clin Med       Date:  2022-09-28       Impact factor: 4.964

5.  Role of Renal Re-transplantation in ESRD Patients.

Authors:  Alireza Ghadian; Mohammad Hossein Nourbala
Journal:  Nephrourol Mon       Date:  2013-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.